XML 17 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Operating activities:    
Net loss $ (2,135) $ (12,288)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Amortization and impairment of software development costs and licenses 63,459 40,719
Depreciation and amortization 14,869 13,928
Amortization and impairment of intellectual property   160
Stock-based compensation 33,333 35,406
Deferred income taxes (15) 68
Amortization of discount on Convertible Notes 12,981 11,544
Amortization of debt issuance costs 779 792
Other, net (2,897) 1,102
Changes in assets and liabilities:    
Restricted cash (106,940) (45,548)
Accounts receivable (212,032) (22,668)
Inventory (62,555) (3,755)
Software development costs and licenses (148,512) (117,959)
Prepaid expenses, other current and other non-current assets (8,560) (13,250)
Deferred revenue 80,913 113,042
Deferred cost of goods sold (17,287) (38,440)
Accounts payable, accrued expenses and other liabilities 303,790 57,161
Net cash (used in) provided by operating activities (50,809) 20,014
Investing activities:    
Change in bank time deposits 66,841 (162,401)
Proceeds from available-for-sale securities 72,387  
Purchases of available-for-sale securities (74,552) (4,987)
Purchases of fixed assets (8,283) (25,793)
Proceeds from sale of long-term investment 1,350  
Purchase of long-term investments (1,885)  
Net cash provided by (used in) investing activities 55,858 (193,181)
Financing activities:    
Excess tax benefit from stock-based compensation 1,143 9,529
Tax payment related to net share settlements on restricted stock awards (30,621) (10,386)
Repurchase of common stock   (26,552)
Net cash used in financing activities (29,478) (27,409)
Effects of foreign currency exchange rates on cash and cash equivalents (4,310) 1,169
Net decrease in cash and cash equivalents (28,739) (199,407)
Cash and cash equivalents, beginning of year 798,742 911,120
Cash and cash equivalents, end of year $ 770,003 $ 711,713